Similar articles

• Long-Term Follow-Up of Outcomes With F-18-Fluorodeoxyglucose Positron Emission Tomography Imaging-Assisted Management of Patients With Severe Left Ventricular Dysfunction Secondary to Coronary Disease.

  Mc Ardle B, Shukla T, Nichol G, deKemp RA, Bernick J, Guo A, Lim SP, Davies RA, Haddad H, Duchesne L, Hendry P, Masters R, Ross H, Freeman M, Gulenchyn K, Racine N, Humen D, Benard F, Ruddy TD, Chow BJ, Mielniczuk L, DaSilva JN, Garrard L, Wells GA, Beanlands RS; PARR-2 Investigators. Mc Ardle B, et al. Circ Cardiovasc Imaging. 2016 Sep;9(9):e004331. doi: 10.1161/CIRCIMAGING.115.004331. Circ Cardiovasc Imaging. 2016. PMID: 27609816 Clinical Trial.
• Prospective Evaluation of 18F-Fluorodeoxyglucose Uptake in Postischemic Myocardium by Simultaneous Positron Emission Tomography/Magnetic Resonance Imaging as a Prognostic Marker of Functional Outcome.

  Rischpler C, Dirschinger RJ, Nekolla SG, Kossmann H, Nicolosi S, Hanus F, van Marwick S, Kunze KP, Meinicke A, Götze K, Kastrati A, Langwieser N, Ibrahim T, Nahrendorf M, Schwaiger M, Laugwitz KL. Rischpler C, et al. Circ Cardiovasc Imaging. 2016 Apr;9(4):e004316. doi: 10.1161/CIRCIMAGING.115.004316. Circ Cardiovasc Imaging. 2016. PMID: 27056601 Free PMC article.
• Positron emission tomography for assessment of viability.

  Sawada SG. Sawada SG. Curr Opin Cardiol. 2006 Sep;21(5):464-8. doi: 10.1097/01.hco.0000240583.91591.a8. Curr Opin Cardiol. 2006. PMID: 16900009 Review.
• [Positron emission tomography with (18)F-fluoro-2-deoxyglucose in cardiological diagnosis].

  Zaplatnikov K, Menzel K, Döbert N, Hamscho N, Grünwald F. Zaplatnikov K, et al. Kardiologiia. 2005;45(2):90-9. Kardiologiia. 2005. PMID: 15798720 Review. Russian.
• Role of F-18 FDG positron emission tomography (PET) in the assessment of myocardial viability.

  Ghesani M, Depuey EG, Rozanski A. Ghesani M, et al. Echocardiography. 2005 Feb;22(2):165-77. doi: 10.1111/j.0742-2822.2005.04032.x. Echocardiography. 2005. PMID: 15693785 Review.